Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.11.27.568898

Role of HNF4alpha-cMyc Interaction in CDE-diet Induced Liver Injury and Regeneration

Abstract

BackgroundHepatocyte nuclear factor 4 alpha (HNF4) is a nuclear factor essential for liver function and regeneration. HNF4 negatively regulates the expression of cMyc, which plays an important role in proliferation and differentiation during liver regeneration. This study investigated the role of HNF4-cMyc interaction in regulating liver injury and regeneration using the choline-deficient and ethionine-supplemented (0.15%) (CDE) diet feeding model, which exhibits characteristics of chronic liver diseases including liver injury, inflammation, early fibrotic changes along with hepatocyte and biliary epithelial cell regeneration, and activation of hepatic progenitor cells (HPC). MethodsWild-type (WT), hepatocyte-specific knockout of HNF4 (HNF4-KO), cMyc (cMyc-KO), and HNF4-cMyc double knockout (DKO) mice were fed a CDE diet for one week to induce subacute liver injury. To study regeneration and recovery, mice were fed a one-week CDE diet followed by a one-week recovery period on a normal chow diet. ResultsWT mice showed significant liver injury and decreased HNF4 mRNA and protein expression after one week of a CDE diet. WT mice also showed an increase in markers of proliferation and HPC activation, but no major change in markers of inflammation or fibrosis. The HNF4-KO mice exhibited baseline hepatomegaly, which significantly declined during the recovery period. HNF4 deletion resulted in significantly higher injury compared to WT mice after one week of CDE diet feeding but similar recovery. Markers of inflammation, fibrosis, proliferation, and HPC activation were significantly higher in HNF4-KO mice during the injury period but declined during the recovery period. The cMyc-KO mice showed increased injury after one week of the CDE diet, but it was substantially lower than the WT and HNF4-KO mice. Deletion of cMyc resulted in a significant activation of inflammatory genes higher than in the WT and HNF4-KO mice. Whereas fibrosis and proliferation markers increased in cMyc-KO mice, they were substantially lower than in HNF4-KO mice and similar to WT mice. cMyc-KO also showed an increase in HPC markers following one week of CDE-induced injury. Deletion of both HNF4 and cMyc in DKO mice resulted in significant liver injury comparable to the HNF4-KO mice after one week of CDE diet feeding, but led to complete recovery. Markers of inflammation, fibrosis, and proliferation increased after CDE diet feeding, were higher than WT mice, and comparable to HNF4-KO mice. Interestingly, DKO mice showed a significant increase in HPC markers both following one week of CDE-induced injury and after one week of recovery. ConclusionsThese data indicate that deletion of HNF4 increases and deletion of cMyc decreases subacute liver injury induced by a one week CDE diet feeding. Deletion of HNF4 results in increased inflammation, fibrosis, proliferation, and HPC activation, all of which except inflammation are reduced following cMyc deletion. Simultaneous deletion of HNF4 and cMyc results in a phenotype similar to HNF4 deletion but with higher HPC activation. Taken together, these data show that HNF4 protects against inflammatory and fibrotic change following CDE diet-induced injury, which is driven by cMyc.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kotulkar, M., Barbee, J., Robarts, D., Paine-Cabrera, D., Apte, U.. 2023-11-27. Role of HNF4alpha-cMyc Interaction in CDE-diet Induced Liver Injury and Regeneration. https://doi.org/10.1101/2023.11.27.568898

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

Identification of Novel Inhibitors of JEV RdRp as Potent Antiviral Drugs: Targeting NS5-NS3 Protein Interaction

Japanese Encephalitis Virus (JEV) belongs to the Flavivirus family, and the RNA dependent RNA polymerase (RdRp) domain located at the C terminus of non structural protein 5 (NS5) regulates de novo viral genome synthesis. The conserved priming loop inserted in the thumb domain of RDRP initiates de novo genome synthesis. Interestingly, the reported replication process initiates with an interaction between NS5 (methyltransferase/RDRP) and NS3 (protease/helicase), and inhibiting this interaction directly correlates with the inhibition of viral replication. The function of the priming loop in the context of the NS5 NS3 interaction is not yet known. In this study, we studied the priming loop function in the NS5 NS3 interaction and viral replication. Using a structure based drug design approach, we screened the Maybridge compound library against the RdRp priming loop and identified 15 candidate compounds based on binding energy. Among them, DSHS00151 showed significant dose dependent inhibition of the NS5 NS3 interaction with an IC50 of 3.5 micromolar in the mammalian two hybrid assay, inhibited viral infectivity with an IC50 of 2.54 micromolar, and reduced viral RNA load with an IC50 of 2.9 micromolar, compared to CD10712. Molecular Dynamics (MD) simulations revealed that DSHS00151 exhibits stronger and more stable binding with the priming loop residues (790 to 812) compared to CD10712. The molecular mechanism suggested by the docking of the NS5 and NS3 proteins showed that the priming loop tends to rotate toward the NS3 protein to stabilize the complex, and compound binding restricts this loop rotation, thus compromising the stability of the NS5 and NS3 complex and affecting viral replication. Overall, our study validated the function of the NS5 priming loop as an allosteric site, and compounds binding to this allosteric site belong to the Non Nucleoside Reverse Transcriptase Inhibitors (NNRTI) class of inhibitors, which disrupt the NS5 and NS3 interaction and could be developed as novel anti JEV therapeutics.

pathology↗

Autophagic flux is increased in peripheral blood mononuclear cells in atherosclerotic vascular disease and associates inversely with adverse cardiovascular events

Background: Autophagy is a homeostatic pathway supporting stress adaptation and is dysregulated in atherosclerosis. Its potential as a biomarker or therapeutic target in atherosclerotic vascular disease (ASVD) remains incompletely defined. We measured autophagic flux in peripheral blood mononuclear cells (PBMCs) from patients with peripheral arterial disease (PAD) or carotid stenosis (CS), compared with healthy controls, and explored clinical outcome associations. Methods: Ninety-four patients with PAD or CS and 19 healthy controls were studied. Autophagic flux was quantified from fresh blood using a validated ex vivo chloroquine inhibition ELISA measuring LC3BII accumulation. Major adverse cardiovascular events (MACE) and major adverse limb events (MALE) were ascertained over a median follow up of 828 days. Results: The ASVD cohort comprised claudication (n = 16), chronic limb threatening ischemia (CLTI; n = 49), and CS (n = 29). Autophagic flux was higher in ASVD than controls (mean 281.4 vs. 182.3 ng LC3BII/mg protein/h; p < 0.0001) and remained independently associated after multivariable adjustment. Within CLTI, concurrent infection was associated with lower flux (p = 0.001), approaching control levels (p = 0.327). In CLTI, higher flux quartiles were associated with lower MACE risk, most strongly for quartile 3 (hazard ratio 0.07 vs. quartile 1, 95% CI 0.01 to 0.50; p = 0.009). Conclusion: Autophagic flux is elevated in PBMCs from ASVD patients, independent of age and sex. Attenuated flux in CLTI with concurrent infection may indicate autophagic exhaustion in advanced disease. The association between higher flux and lower MACE in CLTI suggests prognostic utility, warranting evaluation in larger prospective studies.

pathology↗

Quantitative Model of the Ocular Immune Response during Seasonal Allergic Conjunctivitis

Allergic conjunctivitis is an inflammation of the conjunctiva caused by allergen; it is common disorder affecting up to 40% of the population. In this work, we study seasonal allergic conjunctivitis (SAC), also called "hay fever eyes", which is caused by exposure to airborne pollens. We develop a mathematical model quantifying the ocular immune system response to the allergens. First, we present a simplified qualitative description of the immunopathogenesis of SAC. Then, we express each chosen immunopathological mechanism mathematically to construct a system of thirty-one ordinary differential equations. We compare summary statistics of the predicted observable immune signals to experimental measurements and find our model captures key qualitative features of SAC progression. We then compare our predicted time series of histamine concentration to symptom scores and find a strong correlation suggesting the model predicts relevant clinically trends. Next, we calibrate the model through multi-step process. We find the most influential parameters are the production and depletion rates of IL-4, and the production rates of IL-5 and IL-8. These cytokines are targeted in treatments for asthma, atopic dermatitis, and severe eosinophilic associated disorder and suggest potential therapeutic targets for SAC. Our calibrated model mimics most of the summary statistics of the experimentally observable immune signals with discrepancies for IL-5 and IL-13 indicating that additional immunopathological mechanisms could be important.

pathology↗